How were Spring Bank Pharmaceuticals' earnings last quarter?

Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) issued its earnings results on Sunday, November, 8th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.06.

What other stocks do shareholders of Spring Bank Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spring Bank Pharmaceuticals investors own include Intelsat (I) , AMC Entertainment (AMC) , Bank of America (BAC) , Fossil Group (FOSL) , Associated British Foods (ABF) , Apollo Global Management (APO) , Chaarat Gold (CGH) , SCYNEXIS (SCYX) , Avadel Pharmaceuticals (AVDL) and China Unicom (Hong Kong) (CHU) .

When did Spring Bank Pharmaceuticals IPO?

Spring Bank Pharmaceuticals (SBPH) raised $14 million in an IPO on Friday, May 6th 2016. The company issued 1,100,000 shares at $12.00-$14.00 per share. Dawson James Securities served as the underwriter for the IPO.

NASDAQ:SBPH

Spring Bank Pharmaceuticals (SBPH) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free SBPH Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $1.21
▼
$10.39
52-Week Range: N/A

Volume: N/A
Average Volume: 177,606 shs
Market Capitalization: $122.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Spring Bank Pharmaceuticals alerts:

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Spring Bank Pharmaceuticals Stock (NASDAQ:SBPH)

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of a range of cancers and inflammatory diseases using its proprietary small molecule nucleotide platform. The company is developing SB 11285, a next-generation immunotherapeutic cyclic dinucleotide for the treatment of selected cancers; novel STING antagonist compounds for the treatment of autoimmune and inflammatory diseases; and novel platform to enable the targeted delivery of payload molecules. It has a collaboration agreement with with Roche to explore the co-administration of SB 11285. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Hopkinton, Massachusetts.

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

SBPH Stock News Headlines

January 31, 2024 | thetimes.co.uk

When will interest rates go down?

January 6, 2024 | ca.finance.yahoo.com

Bank of Canada expected to 'cautiously' start cutting rates in spring: Deloitte Canada

April 19, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

September 29, 2023 | hulldailymail.co.uk

Man stabbed during street fight in Spring Bank West

August 8, 2023 | hulldailymail.co.uk

Spring Bank fight involved two feuding families, police believe

August 8, 2023 | hulldailymail.co.uk

Calls for more police patrols on Spring Bank after fight leaves three in hospital

August 7, 2023 | hulldailymail.co.uk

Spring Bank fight: Six men and a woman held over shocking street violence

August 5, 2023 | hulldailymail.co.uk

The mysterious structure on Spring Bank created to shoot out a beam of light

April 19, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

June 30, 2023 | hulldailymail.co.uk

Hull's Spring Bank set for major regeneration as plans announced to make it more 'attractive'

June 14, 2023 | forbes.com

Spring 2023 Layoff Tracker: Grubhub Cuts 400 Staff

May 20, 2023 | uk.news.yahoo.com

When is the the next UK Bank Holiday and how many are left in 2023?

March 26, 2023 | cbsnews.com

Best St. Patrick's Day deals on Amazon: Save big on spring cleaning, Apple tech and more

March 22, 2023 | cbsnews.com

Miami Beach enacts spring break curfew after 2 fatal shootings

March 20, 2023 | nytimes.com

Spring Returns

March 18, 2023 | nypost.com

Florida fight club: Scantily clad spring break revelers let out pent-up rage in boozy beach brawls

January 22, 2023 | duluthnewstribune.com

St. Scholastica to open spring practice

October 31, 2022 | msn.com

Partying street protesters forced Spring Bank to close

October 9, 2022 | forbes.com

Spring Bank Pharmaceuticals

July 30, 2022 | finance.yahoo.com

‘Pharma bro’ Martin Shkreli is fresh out of prison with a new Web3-crypto ‘drug discovery’ business

July 10, 2022 | finance.yahoo.com

Springfield-area consumers get some relief at the pump as prices drop below $5

December 29, 2021 | fool.com

Spring Bank Pharmaceuticals(SBPH)

See More Headlines

Receive SBPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spring Bank Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/08/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:SBPH
CUSIP: N/A
CIK: 1566373
Web: www.springbankpharm.com
Phone: 508-473-5993
Fax: N/A
Employees: 30
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.47)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-24,100,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -89.89%
Return on Assets: -52.89%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.11
Quick Ratio: 5.11

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.16 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 17,267,000
Free Float: N/A
Market Cap: $122.94 million
Optionable: Not Optionable
Beta: 1.07

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Martin J. Driscoll (Age 61)
Pres, CEO & Director
Comp: $568.08k
Dr. Radhakrishna P. Iyer Ph.D. (Age 70)
FRSC, Co-Founder & Chief Scientific Officer
Comp: $452.04k
Ms. Lori C. Firmani (Age 47)
VP of Fin., Treasurer, Principal Financial Officer & Principal Accounting Officer
Mr. Donald Mitchell MBA
VP of Operations & Corp. Devel.
Mr. Garrett Winslow (Age 41)
VP of Legal, Sec. & Gen. Counsel
Dr. Nezam H. Afdhal (Age 63)
Chief Medical Officer
Dr. Atif Abbas
VP and Head of Oncology & Immunology Clinical Devel.

Key Competitors

View All Competitors

SBPH Stock Analysis - Frequently Asked Questions

How were Spring Bank Pharmaceuticals' earnings last quarter?: Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) issued its earnings results on Sunday, November, 8th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.06.
What other stocks do shareholders of Spring Bank Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Spring Bank Pharmaceuticals investors own include Intelsat (I), AMC Entertainment (AMC), Bank of America (BAC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), SCYNEXIS (SCYX), Avadel Pharmaceuticals (AVDL) and China Unicom (Hong Kong) (CHU).
When did Spring Bank Pharmaceuticals IPO?: Spring Bank Pharmaceuticals (SBPH) raised $14 million in an IPO on Friday, May 6th 2016. The company issued 1,100,000 shares at $12.00-$14.00 per share. Dawson James Securities served as the underwriter for the IPO.

This page (NASDAQ:SBPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Spring Bank Pharmaceuticals (SBPH) Stock Price, News & Analysis

About Spring Bank Pharmaceuticals Stock (NASDAQ:SBPH)

SBPH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SBPH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info